Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

NCT03038308 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Hyperprolactinemia
Prolactinoma

Interventions

DRUG: Ropinirole

Sponsor

Columbia University

Collaborators

[object Object]